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Abstract
Background: BMP4 is a member of the transforming growth factor beta (TGFbeta) superfamily and Noggin is a
potent BMP inhibitor that exerts its function by binding to BMPs preventing interactions with its receptors. The aim
of this work was to investigate the role of BMP4 and Noggin, on oocytes in vitro maturation (m experiments) and
embryos in vitro development (c experiments) of bovine.
Methods: For m experiments, COCs were collected from slaughterhouse ovaries and in vitro matured in TCM with
100 ng/ml of either BMP4 or Noggin. After 24 h, the nuclear stage of the oocytes was determined by staining with
Hoechst 33342. In addition, RT-qPCR was performed on MII oocytes to study the relative concentration of ZAR1,
GDF9, BAX, MATER and HSP70 transcripts. Treated oocytes were submitted to parthenogenic activation (PA) or in
vitro fertilization (IVF) and cultured in CR2. For c experiments, non-treated matured oocytes were submitted to PA
or IVF to generate embryos that were exposed to 100 ng/ml of BMP4 or Noggin in CR2 until day nine of culture.
Cleavage, blastocyst and hatching rates, expression pattern of the transcription factor Oct-4 in blastocysts and
embryo cell number at day two and nine post-activation or fertilization were evaluated.
Results: We found that Noggin, as BMP4, did not affect oocyte nuclear maturation. Noggin supplementation
up-regulated the expression of HSP70 and MATER genes in matured oocytes. Moreover, BMP4 during maturation
increased the proportion of Oct-4 positive cells in parthenogenic embryos. On the other hand, when Noggin was
added to embryo culture medium, developmental rates of parthenogenic and in vitro fertilized embryos were
reduced. However, BMP4 addition decreases the development only for in vitro fertilized embryos. BMP4 and
Noggin during culture reduced the proportion of Oct-4-expressing cells.
Conclusions: Our results show that BMP4 is implicated in bovine oocytes maturation and embryo development.
Moreover, our findings demonstrate, for the first time, that a correct balance of BMP signaling is needed for proper
pre-implantation development of bovine embryos.
Background
Bone Morphogenetic Protein 4 is a member of the
transforming growth factor beta (TGFb)s u p e r f a m i l y
which controls numerous events of embryonic, fetal and
even adult development in all vertebrates [1]. Intracellu-
lar mediators of BMPs are Smad proteins which form a
complex that is then translocated to the nucleus and
regulates gene expression [2]. Noggin is a potent inhibi-
tor of BMPs that directly binds to BMP members, speci-
fically 2, 4 and 7, and blocks the sites required for
interaction with BMP receptors. It belongs to the so
called “ligand traps” group [3] and is a critical regulator
of BMP signaling.
BMP4 is expressed first in stromal cells and later in
follicular development, in theca cells. Its receptors are
found in granulosa cells as well as in the oocyte itself
[4,5] and it is in charge of primordial to primary follicu-
lar transition, stimulates granulose cells proliferation,
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any medium, provided the original work is properly cited.pre-antral follicular growth and follicular survival and
regulates steroideogenesis in granulosa cells [6]. Other
TGFb members, such as BMP15 and GDF9, are
expressed by the oocyte also in many species as cats [7],
mice [8], rats [9], hens [10], goats [11], and cattle [12].
T h ei m p o r t a n c eo fB M P sf o rt h ef e m a l er e p r o d u c t i v e
system has been evidenced by spontaneous mutations of
these genes in sheep [13,14] influencing ovulation rates.
Of all the ovarian BMPs the most associated with the
stem cells properties is in fact BMP4. Therefore, it
could be a potencial regulator of this cell capacity in
bovine embryos. BMP4 maintains the pluripotency of
primordial germ cells [15] and embryonic stem cells
(ESC) in mice [16]. In contrast, BMP4 inhibition with
Noggin is required to maintain pluripotency of embryo-
nic stem cells in the human [17]. In domestic species,
ESCs have not been established yet but a study by Pant
and Keefer [18] showed that BMP4 inhibition with Nog-
gin increases the amount of Nanog transcripts (a pluri-
potent-related factor) in bovine inner cell mass (ICM)
explants. To date, the specific role of this factor in
bovine pluripotent state has not been elucidated. The
POU transcription factor Oct-4, which is also related to
pluripotency, is not expressed only in the ICM in bovine
but it could be implicated in trophoblastic expansion
where intense cellular division precedes differentiation
and so it is important for embryo implantation [19,20].
Moreover, in later developmental stages, BMP4 induces
embryonic and extraembryonic mesoderm formation
[ 2 1 , 2 2 ]a n di sa l s or e l a t e dt ov a s c u l o g e n e s i s[ 2 3 ]i nt h e
embryo as well as in the developing placenta. As a result
it is of major importance in the success of pregnancy.
The aim of this work was to investigate the role of
BMP4 and its inhibitor, Noggin, in oocyte maturation
and development of bovine embryos produced by
parthenogenesis and in vitro fertilization. Several devel-
opmental and molecular aspects were evaluated. These
included meiotic stage and the amount of several tran-
scripts in oocytes, cleavage and blastocyst rates, embryo
cell number and Oct-4 protein expression.
Methods
Reagents
Except where otherwise indicated, all chemicals were
obtained from Sigma Chemical Company (St. Louis,
MO, USA).
Experimental design
Maturation (m) experiments
Oocytes were in vitro matured under three different
conditions [BMP4 (mBMP4), Noggin (mNoggin) and
Control (mControl)] and then submitted to partheno-
genic activation (PA) or in vitro fertilization (IVF).
Nuclear stage was analyzed and transcripts of different
genes were quantified by RT-qPCR on oocytes matured
under the three treatments.
Culture (c) experiments
Embryos were produced by PA or IVF and then cul-
tured in CR2 medium (cControl) or with the addition of
BMP4 (cBMP4) or Noggin (cNoggin).
For both m and c experiments, numbers of cleaved
embryos and their cell numbers were recorded on day
two and numbers of blastocysts and their cell numbers
were recorded on day nine post fertilization/activation.
Oct-4 immunostaining was performed on blastocysts
from the three treatments.
Oocyte collection and maturation
Bovine ovaries were obtained from a slaughter house
and maintained at 25°C until processed. Cumulus-oocyte
complexes (COCs) were aspirated using an 18-G needle
and a 10 ml syringe and rinsed in phosphate buffered
solution (PBS, Gibco 14190, Grand Island, NY, USA)
supplemented with 1% antibiotic-antimycotic (Gibco
15240), and 10% Adult Bovine Serum (Internegocios,
Mercedes, Buenos Aires, Argentine). Maturation was
performed in 100 μl microdroplets of medium 199
(TCM, Gibco 11150) supplemented with 10% Fetal
Bovine Serum (FBS, Internegocios), 1% antibiotic-anti-
mycotic, 20 μM cysteamine (M-9768), 0.1 mM sodium
pyruvate (S-8636), and 2 mM FSH (Folltropin-V,
Bioniche, Belleville, ON, Canada), under mineral oil
(M-8410). Maturation conditions were 6.5% CO2 in
humidified atmosphere at 39°C.
For m experiments, COCs were matured as described
above but FBS was replaced by 0.6% w/v fatty acid-free
bovine serum albumin (faf BSA, A-6003). COCs were
matured in the presence of 100 ng/ml of BMP4 (314-
bp-010, R&D Systems, Minneapolis, MN, USA) or Nog-
gin (N-6784). A Control group consisted of COCs
matured without BMP4 or Noggin.
Nuclear maturation
Cumulus cells were removed from COCs by vortexing
for 3 min in 1mg/ml hyaluronidase (H-4272) in Hepes-
buffered Tyrode’s medium containing albumin, lactate
and pyruvate (TALP-H). After several rinses in TALP-
H, DNA was stained with 2 μg/ml of Hoechst 33342
(B-2261) in TCM for 10 min and oocyte nuclear status
was determined under UV light on an inverted micro-
scope. A holding pipette was used to rotate the oocytes.
Parthenogenic activation
Denuded oocytes were chemically activated in TALP-H
with 5μM ionomycin (I24222, Invitrogen, Chicago, IL,
USA) for 4 min, rinsed several times in TALP-H and
immediately incubated in a 100 μlm i c r o d r o po fT C M
containing 1.9 mM 6-diaminopuridine (D-2629), for 3 h.
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and transferred to culture medium.
In vitro fertilization
F r o z e nb o v i n es p e r mw e r et h a w e da t3 5 ° Ci naw a t e r -
bath and centrifuged twice at 490 g in BO solution [24]
supplemented with 0.4% caffeine (C-4144) and 0.02%
heparin (H-3149) (Sperm washing solution, SWS). The
pellet was resuspended in 50% SWS and 50% BO solution
supplemented with 2% faf BSA. Sperm concentrations
were adjusted to 20 × 10
6 /ml and 100 μl-microdrops
were placed under mineral oil. Following 22 h matura-
tion, COCs were rinsed in TALP-H and co-incubated
with sperm for 5 h. Presumptive zygotes were vortexed
for 30 sec and rinsed three times in TALP-H before
being transferred to culture medium.
Embryo culture
For m experiments, presumptive zygotes were cultured
in 100 μl microdrops of serum-free CR2, without co-
culture. For c experiments, they were randomly assigned
to one of the treatments according to the experimental
design (i.e. serum-free CR2 without co-culture (Control)
or supplemented with 100 ng/ml of either BMP4 or
Noggin). Culture conditions were 6.5% CO2 in humidi-
fied atmosphere at 39°C. Fifty percent of the culture
medium was renewed on days 2, 5 and 7 of culture.
Embryo development
Cleavage, blastocyst and hatching rates were assessed on
day 2 and 9 post fertilization/activation. On day 2,
embryonic cell numbers were recorded using an
inverted microscope.
Blastocyst total cell numbers were assessed on day 9
of culture, by nuclear staining with 2 μg/ml of Hoechst
33342 in CR2 for 10 min. Then, embryos were placed
between a slide and a coverslip and nuclei were counted
under UV light using an inverted microscope.
RNA extraction, quantitative Real Time-Polymerase Chain
Reaction (RT-qPCR)
Denuded oocytes were classified by the presence of the
first polar body, and kept in RNA later
® (AM 7020,
Ambion, Foster City, CA, USA) at -20°C until RNA
extraction. Total RNA extraction was performed using a
Rneasy Micro kit (Qiagen, Valencia, CA, USA) protocol,
according to the manufacturer’s instructions, and treated
with DNAse. Reverse transcriptions were performed
with total RNA from 3 pools of 10 oocytes, using a
Superscript™ III first strand synthesis kit (Invitrogen).
Relative quantification was performed in triplicate using
real time PCR (ABI Prism1 7000, Applied Biosystems,
Foster City, CA, USA) and reactions using a mixture of
iTaqTM SYBR1Green Supermix with ROX (Bio-Rad,
Waltham, MA, USA) with cDNA equivalent to 1.2
oocytes and gene specific primers. Template cDNA was
denatured at 95°C for 10 min, followed by 45 cycles of
95°C for 15 sec; gene-specific primer annealing tempera-
ture was applied for 30 sec, and elongation was carried
out at 72°C for 45 sec/60°C for 30 min (Table 1). After
each PCR run, a melting curve analysis was performed
for each sample to confirm that a single specific product
was generated. Amplicon size was confirmed by ethi-
dium bromide stained-2% agarose gel electrophoresis.
Negative Controls, comprised of the PCR reaction mix
without nucleic acid, were also run with each group of
samples.
Expressions of the GAPDH and b-ACTIN genes were
used as endogenous references and oocytes from Con-
t r o l sw e r eu s e da sc a l i b r a t o r s . Calculations of relative
quantification were performed with the REST 2008 soft-
ware version 2.0.7. Values are shown as n-fold difference
relative to the calibrator. The evaluated transcripts were
related with stress (HSP70), apoptosis (BAX), oocyte
quality (GDF9) and oocyte developmental competence
(MATER and ZAR1).
Immunocytochemistry
Zona-intact blastocysts were fixed in 4% formaldehyde
(F-1635) in PBS for 20 min, rinsed in PBS with 0.4%
BSA (A-7906) for 20 min and permeabilized in 0.1%
Triton-X (T-9284) in PBS for 15 min. Non-specific
immunoreactions were blocked by incubation, for 30
min, in blocking solution consisting of 3% FBS and 0.2%
Tween
® 20 (H5152, Promega, Madison, WI, USA) in
PBS. Incubation with the primary antibody against Oct-
4(goat polyclonal IgG, SC-8628 Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA) diluted 1:100 in blocking
solution, was performed for 1 h. Embryos were then
rinsed in blocking solution for 15 min. Incubation with
the secondary antibody (Alexa 488-donkey anti-goat
IgG, A11055, Molecular Probes Inc. Eugene, OR, USA)
diluted 1:1000 in blocking solution, was performed for
45 min in the dark. Embryos were then rinsed in block-
ing solution and counterstained with 0.01 mg/ml propi-
dium iodide (P-4864) in blocking solution for 10 min in
the dark. Blastocysts not exposed to primary antibody
were used as negative controls. All the stages were per-
formed at room temperature. Embryos were mounted in
a drop of cool 70% glycerol (G-9012) in PBS on a
microscope slide and covered with a coverslip, using
small droplets of wax to protect embryos from collapse.
Images of serial optical sections were recorded every
5μm with a confocal microscope (Olympus FV300),
using software (Olympus Fluoview version 3.3) asso-
ciated with a fluorescence microscope (Olympus BX 61)
and 488 nm and 543 nm lasers to visualize Oct-4 posi-
tive cells and total nuclei respectively.
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Data relative to nuclear stages were analyzed by the
Fisher test. Cleavage, blastocyst and hatching rates were
analyzed by Chi-square test. Blastocyst total cell num-
bers were analyzed by one-way ANOVA, using the
Graph Pad Prism 4 software. Embryo cell number on
day 2 was analyzed with a three by three table and Chi-
square test of independence. The proportion of Oct-4
positive cells over total cell number was analyzed by the
‘Difference of proportions test’ using statistical INFO-
STAT (2007) software. In all cases p < 0.05 was consid-
ered to be significant.
Results
BMP4 and Noggin during maturation
Nuclear maturation and gene expression
The addition of BMP4 or Noggin to in vitro maturation
(IVM) medium did not affect nuclear maturation under
our conditions (Table 2) with most oocytes in all three
groups reaching metaphase II (MII) and extruding the
first polar body.
No differences (p > 0.05) in the relative amount of
ZAR1, GDF9, BAX, MATER and HSP70 transcripts were
observed between mBMP4 and mControl groups, indi-
cating no differential degradation or de novo synthesis
of these messengers in oocytes matured with BMP4. On
the other hand, an up regulation of MATER (mean fac-
tor: 2.484) and HSP70 (mean factor: 1.755) was observed
in mNoggin oocytes (Figure 1).
Parthenogenic activation
After parthenogenic activation, mBMP4 and mNoggin
embryos had higher (p < 0.05) cleavage rates than
mControl but no effect on blastocyst production was
found (Table 3).
In vitro fertilization
After in vitro fertilization, mNoggin cleavage rate was
lower (p < 0.05) than mBMP4 or mControl embryos.
However, blastocyst rates were not affected (p > 0.05)
indicating no effects of the treatments on advanced
Table 1 Primer sequences and PCR conditions
Gene Primer Sequence Annealing
Temperature
Product Length
(bp)
GenBank n° of access/
Reference
HSP70 F5 ’AACAAGATCACCATCACCAACG3’
R5 ’TCCTTCTCCGCCAAGGTGTTG3’
59°C 275 NM174550
BAX F5 ’TTTGCTTCAGGGTTTCATCCAGGA3’
R5 ’CAGCTGCGATCATCCTCTGCAG3’
64°C 174 NM173894
ZAR1 F5 ’TGCCGAACATGCCAGAAG3’
R5 ’TCACAGGATAGGCGTTTGC3’
53°C 188 NM_001076203
MATER F5 ’TAATGACGACGCTGTGTTCTG3’
R5 ’GCGGTTCTCAGGTTCTTCAG3’
53°C 206 NM_001007814
GDF9 F5 ’GACCCCTAAATCCAACAGAA3’
R5 ’AGCAGATCCACTGATGGAA3’
53°C 120 NM_174681
b-ACTIN
(endogenous)
F5 ’GACATCCGCAAGGACCTCTA3’
R5 ’ACATCTGCTGGAAGGTGGAC3’
53°C 205 NM_173979
GAPDH (endogenous) F5 ’CCAACGTGTCTGTTGTGGATCTGA3’
R
5’GAGCTTGACAAAGTGGTCGTTGAG3’
53°C 237 MOUROT et al. [33]
Primer sequences and PCR conditions used for relative gene expression analysis.
Table 2 Meiotic stages of oocytes
Treatment Total MII MI Other Dead
Control 102 81 (79.4) 14 (13.7) 4 (3.9) 2(1.9)
BMP4 98 71 (72.4) 16 (16.3) 0 6 (6.2)
Noggin 89 72 (80.8) 10 (11.2) 2 (2.2) 5 (5.6)
Meiotic stages, determined by nuclear staining of oocytes matured for 24 h in
the presence of 100 ng/ml of BMP4 or Noggin. Control group was matured
without any supplementation (Fisher test). MII: metaphase II; MI: metaphase I.
Other: anaphase and telophase.
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Figure 1 Gene expression in treated oocytes. Quantification of
transcripts by RT-qPCR in BMP4 (white columns) and Noggin (grey
columns)-treated oocytes relative to Control oocytes (mean ±
extreme ratios). Statistical differences respect to Control are
indicated by *(REST software). MATER(mean factor: 2.484) and HSP70
(mean factor: 1.755).
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was not different (p > 0.05) among groups (Table 3).
No differences in embryonic cell numbers were
f o u n do nd a y2( d a t an o ts h o w n )i na l lg r o u p sa n d
blastocysts from the three groups had similar total cell
numbers for PA and IVF (Table 3). These data suggest
that the early kinetics of development of these embryos
were independent of BMP4 and Noggin during in vitro
maturation.
Oct-4 expression in PA and IVF embryos
A higher proportion of Oct-4-expressing cells over total
cells, was observed in mBMP4-PA blastocysts compared
with mControl (p < 0.01) and mNoggin (p < 0.05) PA
blastocysts. No differences among groups were found
for IVF embryos (Table 4).
BMP4 and Noggin during culture
Parthenogenic activation
In PA embryos, the cleavage rate and blastocyst forma-
tion were reduced (p < 0.05) by Noggin when compared
to cBMP4 and cControl embryos (Table 5), showing the
importance of the BMP system for early stages of
development.
On day two of culture there was a marked tendency (p
= 0.057) for cNoggin to have a higher proportion of
two-cell embryos (38% vs. 29%) and a lower proportion
with five to eight cells (15.6% vs. 17.7%) compared with
Controls. This indicates some development retardation
respect to Control. An opposite trend was observed in
cBMP4, which had a higher (p = 0.057) proportion of
embryos with five to eight cells (25.4% vs 17.7%) com-
pared to Controls. No difference in blastocyst total cell
number was found between groups (Table 5).
In vitro fertilization
Noggin during culture negatively affected (p < 0.05)
cleavage, blastocyst and hatching rates while BMP4
addition reduced (p < 0.05) blastocyst and hatching
rates of IVF embryos (Table 5).
No differences in cell number of IVF embryos on day
two of culture were seen so neither acceleration nor
retardation in development was observed. Similarly to
PA embryos, no differences (p > 0.05) in total cell num-
ber of IVF blastocysts were found among groups (Table
5).
Oct-4 expression in PA and IVF embryos
Proportions of Oct-4-expressing cells in IVF embryos
were lower (p < 0.01) in cBMP4 and cNoggin groups
than in cControls (Table 6, Figure 2). No differences
were found in this proportion between treatments in PA
embryos (Table 6). The protein was localized in the
ICM as well as in the trophoblast for all blastocysts.
Discussion
The effects of exogenous BMP4 or its inhibitor, Noggin,
were studied during oocyte in vitro maturation or
embryo culture. We found that whereas BMP4 and
Noggin did not affect nuclear maturation, Noggin sup-
plementation up-regulated the expression of HSP70 and
MATER genes.
The HSP70 gene encodes a heat shock protein that
binds several proteins and its over-expression is usually
associated with stress [25]. In vascular tissues, Hsp70
protein can enhance BMP activity by binding BMP inhi-
bitors and it can be a possible link between cellular
stress and BMP signaling [26]. From our finding, we
speculate that the increase of HSP70 transcripts could
be an effort by the cell to keep BMPs at adequate levels
or to minimize possible stresses induced by Noggin.
Mater is a maternal effect protein that plays an essen-
tial role on early embryo development in the mouse
[27], but its role in other species is not well known.
Mota et al [28] reported no variation in MATER gene
expression between bovine oocytes with low and high
competence. Whereas Pennetier et al [29] found that
MATER mRNA amount decreases strongly during
m a t u r a t i o na n dW o o de ta l .[ 3 0 ]f o u n do v e r - e x p r e s s i o n
in oocytes from women with polycystic ovarian syn-
drome. Our work found a higher relative abundance of
MATER transcripts in oocytes matured with Noggin.
This could be associated with a deficient cytoplasmic
maturation nevertheless we did not find differences in
blastocyst rates.
Table 3 Effect of BMP4 and Noggin added to in vitro maturation medium on development of parthenogenic and in
vitro fertilized embryos
Treatment Total Cleaved (%) Blastocysts (%) Hatching blast. (%) Blastocyst cell number ± sd
Control 344 190 (55.2)
b 30 (8.7) 100 ± 33
PA BMP4 274 180 (65.7)
a 22 (8.0) 1 (0.4) 88 ± 14
Noggin 242 158 (65.3)
a 22 (9.0) 68 ± 8
Control 249 176 (70.7)
a 35 (14.0) 5 (2.0) 90 ± 25
IVF BMP4 221 160 (72.4)
a 28 (12.6) 4 (1.8) 120 ± 25
Noggin 234 144 (61.5)
b 31(13.2) 2 (0.8) 99 ± 8
Development of parthenogenic (PA) and in vitro fertilized (IVF) embryos produced from oocytes that were matured in the presence of 100 ng/ml of BMP4 or
Noggin. Controls were matured in standard medium without supplementation. Different superscripts in PA or IVF indicate statistical differences (Chi-square test,
p < 0.05). For blastocyst cell numbers, one-way ANOVA was applied.
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stage was not affected by the addition of BMP4 to the
IVM medium which is consistent with Fatehi et al [4]
results. In this work, we have also tested the effects of
the inhibitor Noggin but no differences in nuclear
maturation were observed.
Supplementation of media with BMP4 or its inhibitor
during in vitro maturation had different effects on early
embryonic development depending on whether the
embryos were parthenogenic or in vitro fertilized with no
effect on subsequent development. Similar results were
p u b l i s h e db yF a t e h ie ta l[ 4 ]only for maturation with
BMP4 prior to IVF. However, despite blastocysts rates
were similar, a higher proportion of Oct-4-expressing
cells was observed in parthenogenic blastocysts obtained
from oocytes matured with exogenous BMP4.
Although BMP4 has been well studied during organo-
genesis and extra-embryonic differentiation, BMP4 func-
tion during in vitro embryo development to the
blastocyst stage has not been previously studied in the
bovine. In a second set of experiments, we have
addressed this study and BMP4 and Noggin were
included in the embryo culture medium. We found that
Noggin decreased cleavage, blastocyst and hatching rates
of both PA and IVF embryos, showing the importance
of BMP system for embryo development. This negative
effect could be related to the lower proportion of Oct-4-
expressing cells observed in IVF embryos. Coincidently,
the same effects on blastocyst formation and Oct-4
expression pattern were observed for BMP4 during the
culture of IVF embryos. In mice, Murohashi et al [31]
observed a lower ratio of ICM-derived cells over tro-
phoectoderm-derived cells in blastocysts cultured and
treated with Noggin, than Controls. It is possible that
our results were related to similar effects on the pluripo-
tency capacity of the embryos.
Although BMP4 addition to the culture medium did
not affect cleavage rates for PA or IVF embryos, the rate
of blastocyst production was reduced for IVF embryos,
but not for PA embryos. These results suggest differ-
ences, in the BMP system, between PA and IVF
embryos. This could be caused by the different imprint-
ing pattern of both types of embryos [32]. PA embryos
only contain maternal genome which could, in turn,
cause differences at many levels e.g. expression of BMP
ligands, receptors, intracellular mediators, etc.
In summary, we proof that Noggin, as BMP4, did not
affect oocyte nuclear maturation. Noggin supplementa-
tion up-regulated the expression of HSP70 and MATER
genes in matured oocytes. Moreover, BMP4 during
maturation increased the proportion of Oct-4 positive
cells in parthenogenic embryos. On the other hand,
when Noggin was added to embryo culture medium,
developmental rates of parthenogenic and in vitro
Table 4 Oct-4 expression in PA and IVF blastocysts from
in vitro maturation experiments
Treatment n Total
cells
Oct-4 positive
cells
% Oct-4/Total
cells
PA Control 3 194 122 63
b**
BMP4 2 100 79 79
a
Noggin 3 240 157 65
b*
IVF Control 2 136 103 76
BMP4 3 151 119 79
Noggin 3 307 218 71
Oct-4 expression in PA and IVF blastocysts produced from oocytes that were
matured with 100 ng/ml of either BMP4 or Noggin, Controls were matured
without supplementation. Different superscripts indicate statistical differences,
‘Difference of proportions test’ *p < 0.05; **p < 0.01.
Table 5 Effect of BMP4 and Noggin added to culture medium on development of parthenogenic and in vitro fertilized
embryos
Treatment Total Cleaved (%) Blastocysts (%) Hatching blast. (%) Blastocyst cell number ± sd
Control 354 237 (66.9)
a 48 (13.5)
a 68 ± 33
PA BMP4 295 199 (67.4)
a 44 (14.9)
a 1 (0.3) 91 ± 43
Noggin 269 154 (57.2)
b 19 (7.0)
b 71 ± 16
Control 218 138 (63.3)
a 45 (20.6)
a 10 (4.6)
a 130 ± 47
IVF BMP4 217 146 (61.3)
ab 22 (9.2)
b 3 (1.4)
b 117 ± 52
Noggin 205 105 (51.2)
b 24 (11.7)
b 1 (0.5)
b 128 ± 21
Development of parthenogenic (PA) and in vitro fertilized (IVF) embryos cultured with 100 ng/ml of either BMP4 or Noggin, Controls were cultured without
supplementation. Different superscripts in PA or IVF indicate statistical differences Chi-square test (p < 0.05). For blastocyst cell numbers, one-way ANOVA was
applied.
Table 6 Oct-4 expression in PA and IVF blastocysts from
in vitro culture experiments
Treatment N Total
cells
Oct-4 positive
cells
% Oct-4/Total
cells
PA Control 3 163 129 79
BMP4 3 180 142 79
Noggin 2 115 84 73
IVF Control 3 275 229 83
a
BMP4 3 324 235 72
b**
Noggin 3 256 185 72
b**
Oct-4 expression in PA and IVF blastocysts. Embryos were cultured with
100 ng/ml of either BMP4 or Noggin, Controls were cultured without
supplementation. Different superscripts indicate statistical differences,
‘Difference of proportions test’ **p < 0.01.
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tion decreases the development only for in vitro ferti-
lized embryos. BMP4 and Noggin during culture
reduced the proportion of Oct-4-expressing cells.
Conclusions
Our results show that BMP4 is implicated in bovine
oocytes maturation with effects on cleavage rates and
pluripotent state of blastocyst cells; and Noggin modifies
the expression of some genes in oocytes. Moreover our
findings demonstrate, for the first time, that a correct
balance of BMP signaling is needed for proper pre-
implantation development of bovine embryos.
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